COP — CompuGroup Medical SE & Co KgaA Balance Sheet
0.000.00%
- €1.16bn
- €1.86bn
- €1.15bn
- 78
- 39
- 80
- 77
Annual balance sheet for CompuGroup Medical SE & Co KgaA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 77.3 | 110 | 93.1 | 69.1 | 108 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 187 | 213 | 271 | 252 | 244 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 308 | 371 | 421 | 370 | 395 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 136 | 158 | 161 | 166 | 167 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,566 | 1,791 | 1,944 | 1,900 | 1,966 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 291 | 398 | 375 | 345 | 331 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 927 | 1,179 | 1,272 | 1,232 | 1,318 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 639 | 612 | 672 | 668 | 648 |
| Total Liabilities & Shareholders' Equity | 1,566 | 1,791 | 1,944 | 1,900 | 1,966 |
| Total Common Shares Outstanding |